Publications
2024
- PublishedA hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial
Smith, T., West, C., Joseph, N., Lane, B., Irlam-Jones, J., More, E., Mistry, H., Reeves, K., Song, Y. P., Reardon, M., Hoskin, P., Hussain, S., Denley, H., Hall, E., Porta, N., Huddart, R., James, N. & Choudhury, A., 1 Mar 2024, In: eBioMedicine. 101, p. 105032 14 p., 105032.
Research output: Contribution to journal › Article › peer-review - PublishedCRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer
Smith, D., Lunj, S., Adamson, A., Nagarajan, S., Smith, T., Reeves, K., Hoskin, P. & Choudhury, A., 1 Jul 2024, In: Nature Reviews Urology. 21, p. 1-11 11 p.
Research output: Contribution to journal › Review article › peer-review - PublishedGene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response
Smith, T., 26 May 2024, In: Genes. 15, 6, p. 688 16 p., 15060688.
Research output: Contribution to journal › Review article › peer-review - PublishedImplementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts
Shabbir, R., Telfer, B., Dickie, B., Reardon, M., Babur, M., Williams, K., Choudhury, A., West, C. & Smith, T., 27 Jun 2024, In: Cancer Genomics & Proteomics. 21, 4, p. 380-387 8 p.
Research output: Contribution to journal › Article › peer-review